Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis

被引:92
|
作者
Marra, Alexandre R. [1 ,2 ,3 ]
Perencevich, Eli N. [1 ,3 ]
Nelson, Richard E. [4 ,5 ]
Samore, Matthew [4 ,5 ]
Khader, Karim [4 ,5 ]
Chiang, Hsiu-Yin [6 ]
Chorazy, Margaret L. [1 ]
Herwaldt, Loreen A. [1 ]
Diekema, Daniel J. [1 ]
Kuxhausen, Michelle F. [7 ]
Blevins, Amy [8 ]
Ward, Melissa A. [1 ]
McDanel, Jennifer S. [1 ]
Nair, Rajeshwari [1 ,3 ]
Balkenende, Erin [1 ]
Schweizer, Marin L. [1 ,3 ]
机构
[1] Univ Iowa, Dept Internal Med, Carver Coll Med, 200 Hawkins Dr, Iowa City, IA 52242 USA
[2] Hosp Israelita Albert Einstein, Div Med Practice, Sao Paulo, Brazil
[3] Iowa City VA Hlth Care Syst, Ctr Access & Delivery Res & Evaluat, Iowa City, IA USA
[4] Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA
[5] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA
[6] China Med Univ Hosp, Big Data Ctr, Taichung, Taiwan
[7] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA
[8] Indiana Univ Sch Med, Ruth Lilly Med Lib, Indianapolis, IN 46202 USA
关键词
LENGTH-OF-STAY; RESISTANT STAPHYLOCOCCUS-AUREUS; CARE-ASSOCIATED INFECTIONS; UNITED-STATES; HOSPITAL-ONSET; RISK-FACTORS; INCREASING INCIDENCE; CELL TRANSPLANT; TOTAL HIP; COSTS;
D O I
10.1001/jamanetworkopen.2019.17597
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Key PointsQuestionWhat is the incidence of hospital-onset Clostridium difficile infection (CDI) and its associated length of stay? FindingsThis systematic review and meta-analysis of 13 studies using patient-days as the denominator found that the incidence of hospital-onset CDI was 8.3 cases per 10000 patient-days. Among propensity score-matched studies of the length of stay, the mean difference in length of stay between patients with and those without CDI varied from 3.0 to 21.6 days. MeaningPooled estimates from currently available literature suggest that CDI is associated with a large burden on the US health care system. This systematic review and meta-analysis of 13 studies analyzes the incidence of Clostridium difficile infection and its associated hospital length of stay in the United States. ImportanceAn understanding of the incidence and outcomes of Clostridium difficile infection (CDI) in the United States can inform investments in prevention and treatment interventions. ObjectiveTo quantify the incidence of CDI and its associated hospital length of stay (LOS) in the United States using a systematic literature review and meta-analysis. Data SourcesMEDLINE via Ovid, Cochrane Library Databases via Wiley, Cumulative Index of Nursing and Allied Health Complete via EBSCO Information Services, Scopus, and Web of Science were searched for studies published in the United States between 2000 and 2019 that evaluated CDI and its associated LOS. Study SelectionIncidence data were collected only from multicenter studies that had at least 5 sites. The LOS studies were included only if they assessed postinfection LOS or used methods accounting for time to infection using a multistate model or compared propensity score-matched patients with CDI with control patients without CDI. Long-term-care facility studies were excluded. Of the 119 full-text articles, 86 studies (72.3%) met the selection criteria. Data Extraction and SynthesisTwo independent reviewers performed the data abstraction and quality assessment. Incidence data were pooled only when the denominators used the same units (eg, patient-days). These data were pooled by summing the number of hospital-onset CDI incident cases and the denominators across studies. Random-effects models were used to obtain pooled mean differences. Heterogeneity was assessed using the I-2 value. Data analysis was performed in February 2019. Main Outcomes and MeasuresIncidence of CDI and CDI-associated hospital LOS in the United States. ResultsWhen the 13 studies that evaluated incidence data in patient-days due to hospital-onset CDI were pooled, the CDI incidence rate was 8.3 cases per 10000 patient-days. Among propensity score-matched studies (16 of 20 studies), the CDI-associated mean difference in LOS (in days) between patients with and without CDI varied from 3.0 days (95% CI, 1.44-4.63 days) to 21.6 days (95% CI, 19.29-23.90 days). Conclusions and RelevancePooled estimates from currently available literature suggest that CDI is associated with a large burden on the health care system. However, these estimates should be interpreted with caution because higher-quality studies should be completed to guide future evaluations of CDI prevention and treatment interventions.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] The Risk of Clostridium difficile Associated Diarrhea in Nasogastric Tube Insertion: A Systematic Review and Meta-Analysis
    Wijarnpreecha, Karn
    Sornprom, Suthanya
    Thongprayoon, Charat
    Phatharacharukul, Parkpoom
    Cheungpasitporn, Wisit
    Nakkala, Kiran
    GASTROENTEROLOGY, 2016, 150 (04) : S748 - S748
  • [22] Proton Pump Inhibitors and the Risk of Clostridium difficile Associated Diarrhea: A Systematic Review and Meta-Analysis
    Gupta, Ashutosh
    Attar, Bashar M.
    Agarwal, Rajender
    GASTROENTEROLOGY, 2011, 140 (05) : S210 - S210
  • [23] Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis
    Lau, Christine S. M.
    Chamberlain, Ronald S.
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2016, 9 : 27 - 37
  • [24] Prevalence and Clinical Outcomes of Clostridium difficile Infection in the Intensive Care Unit: A Systematic Review and Meta-Analysis
    Karanika, Styliani
    Paudel, Suresh
    Zervou, Fainareti N.
    Grigoras, Christos
    Zacharioudakis, Ioannis M.
    Mylonakis, Eleftherios
    OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (01):
  • [25] Risk Factors for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis
    Deshpande, Abhishek
    Pasupuleti, Vinay
    Thota, Priyaleela
    Pant, Chaitanya
    Rolston, David D. K.
    Hernandez, Adrian V.
    Donskey, Curtis J.
    Fraser, Thomas G.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2015, 36 (04): : 452 - 460
  • [26] RISK FACTORS FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Deshpande, Abhishek
    Pasupuleti, Vinay
    Thota, Priyaleela
    Pant, Chaitanya
    Rolston, David D.
    Hernandez, Adrian V.
    Donskey, Curtis J.
    Fraser, Thomas
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 : S203 - S204
  • [27] Risk Factors Associated with Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Balram, Bhairavi
    Battat, Robert
    Al-Khoury, Alex
    D'Aoust, Julie
    Afif, Waqqas
    Bitton, Alain
    Lakatos, Peter L.
    Bessissow, Talat
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (01): : 27 - 38
  • [28] Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysis
    Tariq, Raseen
    Mukhija, Dhruvika
    Gupta, Arjun
    Singh, Siddharth
    Pardi, Darrell S.
    Khanna, Sahil
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 405 - 416
  • [29] Diverting Loop Ileostomy for Clostridium Difficile Colitis: A Systematic Review and Meta-analysis
    Shellito, Adam D.
    Russell, Marcia M.
    AMERICAN SURGEON, 2020, 86 (10) : 1269 - 1276
  • [30] RISK FACTORS FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Deshpande, Abhishek
    Pasupuleti, Vinay
    Thota, Priyaleela
    Pant, Chaitanya
    Rolston, David D. K.
    Hernandez, Adrian V.
    Donskey, Curtis J.
    Fraser, Thomas G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (04) : 717 - 717